{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:22:46Z","timestamp":1785363766603,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bmc.2019.07.055","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T01:51:03Z","timestamp":1564969863000},"page":"115039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Fluorescent analogs of peptoid-based HDAC inhibitors: Synthesis, biological activity and cellular uptake kinetics"],"prefix":"10.1016","volume":"27","author":[{"given":"Rick","family":"Raudszus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Nowotny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph G.W.","family":"Gertzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sch\u00f6ler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andor","family":"Krizsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Gockel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Kalwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Gohlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Thieme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn K.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2019.07.055_b0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.08.016","article-title":"HDAC family: what are the cancer relevant targets?","volume":"277","author":"Witt","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bmc.2019.07.055_b0010","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejmech.2016.05.047","article-title":"Inside HDACs with more selective HDAC inhibitors","volume":"121","author":"Roche","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.055_b0015","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.3390\/molecules20033898","article-title":"Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents","volume":"20","author":"Mottamal","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2019.07.055_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-018-0531-y","article-title":"Effects of novel HDAC inhibitors on urothelial carcinoma cells","volume":"10","author":"Kaletsch","year":"2018","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.bmc.2019.07.055_b0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/cbic.201600519","article-title":"Natural and synthetic macrocyclic inhibitors of the histone deacetylase enzymes","volume":"18","author":"Maolanon","year":"2017","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bmc.2019.07.055_b0030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/43710","article-title":"Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors","volume":"401","author":"Finnin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2019.07.055_b0035","first-page":"741","article-title":"Histone deacetylase 6 structure and molecular basis of catalysis and inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"NatChemBiol"},{"key":"10.1016\/j.bmc.2019.07.055_b0040","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.tips.2014.08.001","article-title":"Drugging the HDAC6\u2013HSP90 interplay in malignant cells","volume":"35","author":"Kr\u00e4mer","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmc.2019.07.055_b0045","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1039\/C4MD00350K","article-title":"Discovery of an orally active subtype-selective HDAC inhibitor, chidamide, as an epigenetic modulator for cancer treatment","volume":"5","author":"Pan","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/j.bmc.2019.07.055_b0050","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.drudis.2015.01.007","article-title":"Histone deacetylases: structural determinants of inhibitor selectivity","volume":"20","author":"Micelli","year":"2015","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2019.07.055_b0055","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrg.2016.93","article-title":"Targeting the cancer epigenome for therapy","volume":"17","author":"Jones","year":"2016","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.bmc.2019.07.055_b0060","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ejmech.2017.10.022","article-title":"Discovery of a fluorescent probe with HDAC6 selective inhibition","volume":"141","author":"Zhang","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.055_b0065","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1039\/C5CC10301K","article-title":"Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors","volume":"52","author":"Diedrich","year":"2016","journal-title":"Chem Commun"},{"key":"10.1016\/j.bmc.2019.07.055_b0070","doi-asserted-by":"crossref","first-page":"8054","DOI":"10.1021\/acs.jmedchem.8b01013","article-title":"Histone deacetylase 6-selective inhibitors and the influence of capping groups on hydroxamate-zinc denticity","volume":"61","author":"Porter","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.055_b0075","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ejmech.2018.09.018","article-title":"One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites","volume":"158","author":"Diedrich","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.055_b0080","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1021\/acs.jmedchem.7b00197","article-title":"Design, Multicomponent synthesis, and anticancer activity of a focused histone deacetylase (HDAC) inhibitor library with peptoid-based cap groups","volume":"60","author":"Krieger","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.055_b0085","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1158\/1535-7163.MCT-10-0779","article-title":"Histone deacetylase cytoplasmic trapping by a novel fluorescent HDAC inhibitor","volume":"10","author":"Kong","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmc.2019.07.055_b0090","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.1039\/C5CC02059J","article-title":"A fluorescent histone deacetylase (HDAC) inhibitor for cellular imaging","volume":"51","author":"Fleming","year":"2015","journal-title":"Chem Commun"},{"key":"10.1016\/j.bmc.2019.07.055_b0095","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/cmdc.201500394","article-title":"Multitarget drugs: an epigenetic epiphany","author":"Ganesan","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2019.07.055_b0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13148-016-0271-9","article-title":"Epigenetic polypharmacology: from combination therapy to multitargeted drugs","volume":"8","author":"de Lera","year":"2016","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.bmc.2019.07.055_b0105","doi-asserted-by":"crossref","first-page":"10299","DOI":"10.1021\/acs.jmedchem.8b01487","article-title":"Discovery of the first-in-class dual histone deacetylase-proteasome inhibitor","volume":"61","author":"Bhatia","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.055_b0110","doi-asserted-by":"crossref","first-page":"35402","DOI":"10.1074\/jbc.M807045200","article-title":"Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I histone deacetylases","volume":"283","author":"Chou","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2019.07.055_b0115","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2019.07.055_b0120","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1517\/17460441.2010.484460","article-title":"Virtual screening with AutoDock: theory and practice","volume":"5","author":"Cosconati","year":"2010","journal-title":"Expert Opin Drug Dis"},{"key":"10.1016\/j.bmc.2019.07.055_b0125","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1021\/jm4001659","article-title":"Development and therapeutic implications of selective histone deacetylase 6 inhibitors","volume":"56","author":"Kalin","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.055_b0130","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1021\/acs.jmedchem.6b01538","article-title":"Alkoxyurea-based histone deacetylase inhibitors increase cisplatin potency in chemoresistant cancer cell lines","volume":"60","author":"Stenzel","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.055_b0135","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1039\/C8MD00454D","article-title":"Design, synthesis and biological evaluation of \u03b2-peptoid-capped HDAC inhibitors with anti-neuroblastoma and anti-glioblastoma activity","volume":"10","author":"Re\u00dfing","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.bmc.2019.07.055_b0140","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1021\/jm058214k","article-title":"A new simple and high-yield synthesis of suberoylanilide hydroxamic acid and its inhibitory effect alone or in combination with retinoids on proliferation of human prostate cancer cells","volume":"48","author":"Gediya","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.055_b0145","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1021\/acs.orglett.8b01118","article-title":"Multicomponent Synthesis and Binding Mode of Imidazo[1,2-a]pyridine-Capped Selective HDAC6 Inhibitors","volume":"20","author":"Mackwitz","year":"2018","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2019.07.055_b0150","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0003-2697(03)00276-8","article-title":"Nonisotopic substrate for assaying both human zinc and NAD+-dependent histone deacetylases","volume":"319","author":"Heltweg","year":"2003","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmc.2019.07.055_b0155","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1007\/s10620-017-4821-6","article-title":"Response to TNF-\u03b1 is increasing along with the progression in barrett\u2019s esophagus","volume":"62","author":"Chemnitzer","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bmc.2019.07.055_b0160","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12876-019-0957-5","article-title":"In-depth characterization of the Wnt-signaling\/\u03b2-catenin pathway in an in vitro model of Barrett's sequence","volume":"19","author":"G\u00f6tzel","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.bmc.2019.07.055_b0165","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nprot.2007.202","article-title":"Extraction, purification and analysis of histones","volume":"2","author":"Shechter","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.bmc.2019.07.055_b0170","doi-asserted-by":"crossref","unstructured":"Schr\u00f6dinger Release 2017: Maestro. Schr\u00f6dinger. LLC. New York. NY. 2017.","DOI":"10.2307\/j.ctvcm4h07.63"},{"key":"10.1016\/j.bmc.2019.07.055_b0175","first-page":"655","article-title":"MOLOC: a molecular modeling program","volume":"97","author":"Muller","year":"1988","journal-title":"Bull Soc Chim Belg"},{"key":"10.1016\/j.bmc.2019.07.055_b0180","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00124456","article-title":"MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry","volume":"9","author":"Gerber","year":"1995","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.bmc.2019.07.055_b0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molcel.2013.05.020","article-title":"Class I HDACs share a common mechanism of regulation by inositol phosphates","volume":"51","author":"Millard","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.bmc.2019.07.055_b0190","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/prot.10028","article-title":"Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity in AutoDock","volume":"46","author":"Osterberg","year":"2002","journal-title":"Proteins"},{"key":"10.1016\/j.bmc.2019.07.055_b0195","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2019.07.055_b0200","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1021\/acs.jcim.8b00582","article-title":"Converging a knowledge-based scoring function:drugscore2018","volume":"59","author":"Dittrich","year":"2019","journal-title":"J Chem Inf Model"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619304778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619304778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:02:20Z","timestamp":1760835740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089619304778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":40,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0968089619304778"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2019.07.055","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluorescent analogs of peptoid-based HDAC inhibitors: Synthesis, biological activity and cellular uptake kinetics","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2019.07.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115039"}}